Ads
related to: chemotherapy monitoring chart for cancer research foundation bcrf certification- Donate Now
Make a donation to lifesaving
cancer immunotherapy research.
- What is Immunotherapy?
Unleash the power of the immune
system to fight cancer.
- Ways to Give Back
Take action, give today, and
save lives. Learn more here.
- Make A Sustained Impact
Donate a small amount every month
to support ongoing cancer research.
- Donor Advised Funds
Many CRI donors choose to give
through (DAFs). Learn more.
- Why Donate?
We can change the way cancer is
treated and cured. Make an impact.
- Donate Now
Search results
Results From The WOW.Com Content Network
The Breast Cancer Research Foundation (BCRF) is an independent, not-for-profit organization which has raised $569.4 million to support clinical and translational research on breast cancer at medical institutions in the United States and abroad. [1] BCRF currently funds over 255 researchers in 14 countries. [2]
The North American Association of Central Cancer Registries, Inc. is a professional organization that develops and promotes uniform data standards for cancer registration; provides education and training; certifies population-based registries; aggregates and publishes data from central cancer registries; and promotes the use of cancer surveillance data and systems for cancer control and ...
A chemotherapy regimen is a regimen for chemotherapy, defining the drugs to be used, their dosage, the frequency and duration of treatments, and other considerations. In modern oncology, many regimens combine several chemotherapy drugs in combination chemotherapy. The majority of drugs used in cancer chemotherapy are cytostatic, many via ...
The foundation's namesake, Susan Goodman Komen, died of breast cancer in 1980 at age 36. [8] [9] Her younger sister Nancy Brinker, who has stated that she believed Susan's outcome might have been better had she known more about cancer and its treatment, founded the Susan G. Komen Breast Cancer Foundation in 1982. [9] [10]
Cyclophosphamide Methotrexate Fluorouracil (CMF) is a commonly used regimen of breast cancer chemotherapy that combines three anti-cancer agents: cyclophosphamide, methotrexate, and 5-fluorouracil (5-FU).
"Cancer registrars are data information specialists that capture a complete history, diagnosis, treatment, and health status for every cancer patient in the U.S. The data provide essential information to researchers, healthcare providers, and public health officials to better monitor and advance cancer treatments, conduct research, and improve ...
Cyclophosphamide (CP), also known as cytophosphane among other names, [3] is a medication used as chemotherapy and to suppress the immune system. [4] As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. [4]
ICE in the context of chemotherapy is an acronym for one of the chemotherapy regimens, used in salvage treatment of relapsed or refractory non-Hodgkin's lymphoma and Hodgkin lymphoma. In case of CD20-positive B cell lymphoid malignancies the ICE regimen is often combined today with rituximab. This regimen is then called ICE-R or R-ICE or RICE.
Ad
related to: chemotherapy monitoring chart for cancer research foundation bcrf certification